GSA CAPITAL PARTNERS LLP - DIPLOMAT PHARMACY INC ownership

DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 133 filers reported holding DIPLOMAT PHARMACY INC in Q2 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of DIPLOMAT PHARMACY INC
ValueSharesWeighting
Q2 2019$192,000
-73.0%
31,584
-13.8%
0.02%
-43.6%
Q3 2018$711,000
-12.4%
36,627
-9.5%
0.04%
-20.4%
Q4 2017$812,000
+260.9%
40,450
+522.3%
0.05%
+444.4%
Q1 2015$225,0006,5000.01%
Other shareholders
DIPLOMAT PHARMACY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cortina Asset Management, LLC 1,417,396$28,447,0001.25%
Investors Research Corp 96,550$1,938,0001.20%
Phocas Financial Corp. 663,187$13,310,0001.12%
BROADVIEW ADVISORS LLC 338,000$6,784,0000.96%
Matarin Capital Management, LLC 581,129$11,663,259,0000.91%
Sivik Global Healthcare LLC 100,000$2,007,0000.74%
Iguana Healthcare Management, LLC 50,000$1,004,0000.65%
FRONTIER CAPITAL MANAGEMENT CO LLC 3,824,190$76,751,0000.56%
Capital Impact Advisors, LLC 63,403$1,272,0000.55%
Tekla Capital Management LLC 640,492$12,855,0000.50%
View complete list of DIPLOMAT PHARMACY INC shareholders